Jiayi Shen

ORCID: 0000-0003-4157-7175
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chromatin Remodeling and Cancer
  • Hedgehog Signaling Pathway Studies
  • Genomic variations and chromosomal abnormalities
  • Epigenetics and DNA Methylation
  • Genetics and Neurodevelopmental Disorders
  • Soft tissue tumors and treatment
  • Cancer-related Molecular Pathways
  • Soft tissue tumor case studies
  • Sarcoma Diagnosis and Treatment
  • Genomics and Chromatin Dynamics
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Shanghai Jiao Tong University
2024

Zhejiang University-University of Edinburgh Institute
2022-2024

Second Affiliated Hospital of Zhejiang University
2024

Desmoid tumors are rare neoplasms that locally invasive. However, optimal treatment strategies for recurrent desmoid remain controversial. High-intensity focused ultrasound (HIFU) has been reported as a noninvasive modality treating tumors. its efficacy against massive or those with complex anatomies remains unclear.We developed new therapeutic strategy called low-power cumulative HIFU and applied it to treat tumors.We retrospectively collected data from 91 patients who underwent after...

10.1002/cam4.4573 article EN Cancer Medicine 2022-03-11

Aberrant activation of the Hedgehog (Hh) signaling pathway plays important roles in oncogenesis and therapeutic resistance several types cancer. The clinical application FDA-approved Hh-targeted smoothened inhibitors (SMOi) is hindered by emergence primary or acquired drug resistance. Epigenetic transcriptional-targeted therapies represent a promising direction for developing improved anti-Hh therapies. In this study, we integrated epigenetic/transcriptional-targeted small-molecule library...

10.1158/0008-5472.can-23-3306 article EN Cancer Research 2024-05-22

Abstract Gallbladder cancer (GBC) is a highly aggressive malignancy lacking clinically available targeted therapeutic agents. Super‐enhancers (SEs) are crucial epigenetic cis‐regulatory elements whose extensive reprogramming drives aberrant transcription in cancers. To study SE GBC, the genomic distribution of H3K27ac profiled multiple GBC tissue and cell line samples to establish landscape its associated core regulatory circuitry (CRC). The biliary lineage factor SOX9 Wnt pathway effector...

10.1002/advs.202406448 article EN cc-by Advanced Science 2024-11-04

Introduction Desmoid tumor (DT) is a rare proliferative disease occurring in connective tissues, characterized by high infiltration and recurrence rates. While surgery remains the primary treatment, its risk high, some extra-abdominal desmoid tumors are inoperable due to their locations. Despite attempts with radiotherapy systemic therapy, efficacy limited. Methods We used low-power cumulative high-intensity focused ultrasound (HIFU) therapy as an initial treatment for patients either...

10.3389/fonc.2024.1388302 article EN cc-by Frontiers in Oncology 2024-07-22

<div>Abstract<p>Aberrant activation of the Hedgehog (Hh) signaling pathway plays important roles in oncogenesis and therapeutic resistance several types cancer. The clinical application FDA-approved Hh-targeted smoothened inhibitors (SMOi) is hindered by emergence primary or acquired drug resistance. Epigenetic transcriptional-targeted therapies represent a promising direction for developing improved anti-Hh therapies. In this study, we integrated...

10.1158/0008-5472.c.7403464 preprint EN 2024-08-15

<div>Abstract<p>Aberrant activation of the Hedgehog (Hh) signaling pathway plays important roles in oncogenesis and therapeutic resistance several types cancer. The clinical application FDA-approved Hh-targeted smoothened inhibitors (SMOi) is hindered by emergence primary or acquired drug resistance. Epigenetic transcriptional-targeted therapies represent a promising direction for developing improved anti-Hh therapies. In this study, we integrated...

10.1158/0008-5472.c.7403464.v1 preprint EN 2024-08-15
Coming Soon ...